US EditionAvalo appoints Dr. Rita Jain to BOD - BioTuesdays
Summary by biotuesdays.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Avalo appoints Dr. Rita Jain to BOD - BioTuesdays
Avalo Therapeutics (NASDAQ: AVTX) has announced the appointment of Rita Jain, MD, to its board of directors (BOD). To this role, Dr. Jain, a rheumatologist, brings more than two decades of leadership in biopharmaceutical development, clinical strategy, and regulatory affairs—across multiple therapeutic areas, including immunology, inflammation, nephrology, and rare diseases. She most recently served as EVP and CMO at ChemoCentryx. “We are please…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
